Non-drug-based management of Alzheimer's disease;Prise en charge non médicamenteuse de la maladie d'Alzheimer

Soins Gerontologie

Volumn 18, Issue 102, 2013, Pages 15-17

  De Sant'Anna, Martha ^a   Morat, Brune ^b  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Alzheimer's disease; Cognitive stimulation; Global patient management; Non drug based follow up

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE THERAPY; HUMAN;

AGED; ALZHEIMER DISEASE; COGNITIVE THERAPY; HUMANS;

EID: 84884296982     PISSN: 12686034     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sger.2013.05.004     Document Type: Review

References (15)

1. Requena C, Lopez Ibor MI, Maestu F et al. Effects of cholinergic drugs and cognitive training on dementia. Dementia Geriatric Cognitive Disorders. 2004;18:50-4. (Pubitemid 38822738)
2. De Santánna M, de Rotrou J, Wu YH et al. L'informatisation: Une nouvelle perspective de développement pour la stimulation cognitive ou l'entraînement cognitif. NPG. 2009;56(10):65-70.
3. De Rotrou J, Cantegreil I, Wenisch E et al. Le programme psycho-éducatif dáide aux aidants. Neurologie, Psychiatrie, Gériatrie. 2006;6:19-22. (Pubitemid 44583527)
4. Goldman S. Neurogenesis and neuronal precursor cells in the adult forebrain. Neuroscientists. 1995;1:338-50.
5. Fernandez Ballesteros R, Zamarron MD, Tarraga L. Cognitive Plasticity in healthy, Mild Cognitive Impairment (MCI) subjects and Alzheimer's disease patients: a research project in Spain; Psychology of aging in Europe. Eur Psychol. 2003;8: 148-59.
6. Jones S, Nyberg L, Sandblom J et al. Cognitive and neural plasticity in aging: General and task-specifi c limitations; Methodological and conceptual advances in the study of brainbehavior dynamics: a multivariate lifespan perspective. Neurosci Biobehav Rev. 2006;30:864-71.
7. Tarraga L. La stimulation cognitive, intérêt et limites. Gerontol Soc. 1992;62:91-101.
8. Tarraga L. Tratamientos de psicoestimulacion. En Fernandez Ballesteros R y Diez-Nicolas J (eds): La enfermedad de Alzheimer y trastornos afi nes. Madrid: Obra Social Caja de Madrid; 2001.
9. Dorenlot P. Démence et interventions non médicamenteuses: Revue critique, bilan et perspectives. Psychol Neuropsychiatr du Vieil. 2006;4:135-44. (Pubitemid 43989180)
10. Patterson CJ, Gauthier S, Bergman H et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on dementia. Dementia. 1999;15(Suppl 12):S1-15. (Pubitemid 29312659)
11. Allegri RF, Sarasola D, Serrano CM et al. Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer's disease. Neuropsychiatr Dis Treat. 2006;2:105-10.
12. Brodaty H, Green A, Koschera A. Meta-analysis of psychosocial interventions for caregivers of people with dementia. Journal of American Geriatric Society. 2003;51:657-64. (Pubitemid 36541430)
13. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington DC: American Psychiatric Association; 1994.
14. Smith K, Greenwood C. Weight loss and nutritional considerations in Alzheimer disease. J Nutr Elder. 2008;27(3-4):381- 403.
15. Thomas P, Hazif-Thomas C, Bonduelle P et al. La vulnerabilité de láidant principal des malades déments à domicile, l'étude Pixel. Psychol Neuropsychiatr Vieil. 2005;3:207-20.